Citation: R. Dammann et al., The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas, ONCOGENE, 20(27), 2001, pp. 3563-3567
Citation: P. Hainaut et al., TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database, MUTAGENESIS, 16(6), 2001, pp. 551-553
Citation: P. Hainaut et Gp. Pfeifer, Patterns of p53 G -> T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke, CARCINOGENE, 22(3), 2001, pp. 367-374
Citation: Vm. Arlt et al., Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR, CARCINOGENE, 22(1), 2001, pp. 133-140
Citation: Yh. You et Gp. Pfeifer, Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis, J MOL BIOL, 305(3), 2001, pp. 389-399
Authors:
You, YH
Lee, DH
Yoon, JH
Nakajima, S
Yasui, A
Pfeifer, GP
Citation: Yh. You et al., Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells, J BIOL CHEM, 276(48), 2001, pp. 44688-44694
Citation: Jh. Yoon et al., Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas, INT J CANC, 94(2), 2001, pp. 212-217
Citation: R. Dammann et al., Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in alarge percentage of human breast cancers, CANCER RES, 61(7), 2001, pp. 3105-3109
Authors:
Luo, JL
Tong, WM
Yoon, JH
Hergenhahn, M
Koomagi, R
Yang, Q
Galendo, D
Pfeifer, GP
Wang, ZQ
Hollstein, M
Citation: Jl. Luo et al., UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin, CANCER RES, 61(22), 2001, pp. 8158-8163
Authors:
Yoon, JH
Smith, LE
Feng, ZH
Tang, MS
Lee, CS
Pfeifer, GP
Citation: Jh. Yoon et al., Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: Similarities with the p53 mutation spectrum in smoking-associated lung cancers, CANCER RES, 61(19), 2001, pp. 7110-7117
Authors:
Dammann, R
Li, C
Yoon, JH
Chin, PL
Bates, S
Pfeifer, GP
Citation: R. Dammann et al., Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3, NAT GENET, 25(3), 2000, pp. 315-319
Authors:
Szabo, PE
Tang, SHE
Rentsendorj, A
Pfeifer, GP
Mann, JR
Citation: Pe. Szabo et al., Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function, CURR BIOL, 10(10), 2000, pp. 607-610
Citation: S. Tommasi et al., Cell cycle-independent removal of UV-induced pyrimidine dimers from the promoter and the transcription initiation domain of the human CDC2 gene, NUCL ACID R, 28(20), 2000, pp. 3991-3998
Citation: Hy. You et al., Cyclobutane pyrimidine dimers form preferentially at the major p53 mutational hotspot in UVB-induced mouse skin tumors, CARCINOGENE, 21(11), 2000, pp. 2113-2117
Authors:
Szabo, PE
Pfeifer, GP
Miao, F
O'Connor, TR
Mann, JR
Citation: Pe. Szabo et al., Improved in vivo dimethyl sulfate footprinting using AlkA protein: DNA-protein interactions at the mouse H19 gene promoter in primary embryo fibroblasts, ANALYT BIOC, 283(1), 2000, pp. 112-116
Authors:
Denissenko, MF
Cahill, J
Koudriakova, TB
Gerber, N
Pfeifer, GP
Citation: Mf. Denissenko et al., Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNAusing aflatoxin B1-8,9-epoxide and microsomal activation systems, MUT RES-F M, 425(2), 1999, pp. 205-211
Authors:
Tang, MS
Zheng, JB
Denissenko, MF
Pfeifer, GP
Zheng, Y
Citation: Ms. Tang et al., Use UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene, CARCINOGENE, 20(6), 1999, pp. 1085-1089